ATE215946T1 - Mercaptoalkylpeptidylverbindungen mit einem imidazolsubstituenten und ihre verwendung als inhibitoren der matrix metalloproteinasen (mmp) und/oder des tumor necrosis faktors (tnf) - Google Patents
Mercaptoalkylpeptidylverbindungen mit einem imidazolsubstituenten und ihre verwendung als inhibitoren der matrix metalloproteinasen (mmp) und/oder des tumor necrosis faktors (tnf)Info
- Publication number
- ATE215946T1 ATE215946T1 AT96939208T AT96939208T ATE215946T1 AT E215946 T1 ATE215946 T1 AT E215946T1 AT 96939208 T AT96939208 T AT 96939208T AT 96939208 T AT96939208 T AT 96939208T AT E215946 T1 ATE215946 T1 AT E215946T1
- Authority
- AT
- Austria
- Prior art keywords
- necrosis factor
- mmp
- tnf
- inhibitors
- tumor necrosis
- Prior art date
Links
- 102000002274 Matrix Metalloproteinases Human genes 0.000 title 2
- 108010000684 Matrix Metalloproteinases Proteins 0.000 title 2
- 108060008682 Tumor Necrosis Factor Proteins 0.000 title 2
- 102000003390 tumor necrosis factor Human genes 0.000 title 2
- RAXXELZNTBOGNW-UHFFFAOYSA-N 1H-imidazole Chemical group C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 title 1
- 150000001875 compounds Chemical class 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
- 102000005741 Metalloproteases Human genes 0.000 abstract 1
- 108010006035 Metalloproteases Proteins 0.000 abstract 1
- 102000018594 Tumour necrosis factor Human genes 0.000 abstract 1
- 108050007852 Tumour necrosis factor Proteins 0.000 abstract 1
- 125000002883 imidazolyl group Chemical group 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 125000001151 peptidyl group Chemical group 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/868—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof involving autoimmunity, allergy, immediate hypersensitivity, delayed hypersensitivity, immunosuppression, or immunotolerance
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Urology & Nephrology (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9523828.3A GB9523828D0 (en) | 1995-11-22 | 1995-11-22 | Compounds |
| GBGB9607121.2A GB9607121D0 (en) | 1996-04-04 | 1996-04-04 | Compounds |
| PCT/GB1996/002892 WO1997019075A1 (en) | 1995-11-22 | 1996-11-22 | Mercaptoalkylpeptidyl compounds having an imidazole substituent and their use as inhibitors of matrix metalloproteinases (mmp) and/or tumour necrosis factor (tnf) |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE215946T1 true ATE215946T1 (de) | 2002-04-15 |
Family
ID=26308152
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT96939208T ATE215946T1 (de) | 1995-11-22 | 1996-11-22 | Mercaptoalkylpeptidylverbindungen mit einem imidazolsubstituenten und ihre verwendung als inhibitoren der matrix metalloproteinasen (mmp) und/oder des tumor necrosis faktors (tnf) |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US6048841A (enExample) |
| EP (1) | EP0874842B1 (enExample) |
| JP (1) | JP2000500482A (enExample) |
| KR (1) | KR19990067687A (enExample) |
| CN (1) | CN1072667C (enExample) |
| AT (1) | ATE215946T1 (enExample) |
| AU (1) | AU711907B2 (enExample) |
| BR (1) | BR9611636A (enExample) |
| CA (1) | CA2229438C (enExample) |
| CZ (1) | CZ291337B6 (enExample) |
| DE (1) | DE69620639T2 (enExample) |
| ES (1) | ES2172690T3 (enExample) |
| HU (1) | HUP9904131A3 (enExample) |
| IL (1) | IL123431A (enExample) |
| MX (1) | MX9804052A (enExample) |
| NO (1) | NO982290D0 (enExample) |
| NZ (1) | NZ322565A (enExample) |
| PL (1) | PL326710A1 (enExample) |
| WO (1) | WO1997019075A1 (enExample) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6673927B2 (en) | 1996-02-16 | 2004-01-06 | Societe De Conseils De Recherches Et D'applications Scientifiques, S.A.S. | Farnesyl transferase inhibitors |
| US6953788B1 (en) | 1996-09-19 | 2005-10-11 | Aventis Pharmaceuticals Inc. | 3-mercaptoacetylamino-1,5-substituted-2-oxo-azepan derivatives useful as inhibitors of matrix metalloproteinase |
| RU2201931C2 (ru) | 1996-11-20 | 2003-04-10 | Биомежер Инкорпорэйтед | Ингибиторы фарнезилтрансферазы и способы ингибирования фарнезилтрансферазы |
| MXPA02010993A (es) * | 2000-05-12 | 2003-03-10 | Genzyme Corp | Reguladores de transmision de la tnf-alfa. |
| WO2001087870A1 (en) | 2000-05-15 | 2001-11-22 | Darwin Discovery Limited | Hydroxamic acid derivatives |
| SE0100903D0 (sv) * | 2001-03-15 | 2001-03-15 | Astrazeneca Ab | Compounds |
| SE0100902D0 (sv) * | 2001-03-15 | 2001-03-15 | Astrazeneca Ab | Compounds |
| SE0103710D0 (sv) * | 2001-11-07 | 2001-11-07 | Astrazeneca Ab | Compounds |
| EP1474425B9 (en) * | 2002-01-07 | 2008-07-02 | Eisai Co., Ltd. | Deazapurines and uses thereof |
| SE0202539D0 (sv) * | 2002-08-27 | 2002-08-27 | Astrazeneca Ab | Compounds |
| GB0221246D0 (en) * | 2002-09-13 | 2002-10-23 | Astrazeneca Ab | Compounds |
| PT1562571E (pt) * | 2002-11-21 | 2011-11-25 | Genzyme Corp | Combinação de derivados de diamina e agentes imunossupressores para a indução da tolerância imunológica |
| AU2003291134A1 (en) * | 2002-11-21 | 2004-06-18 | Genzyme Corporation | Use of diamide derivatives for inhibiting chronic tissue transplant rejection |
| US20040259744A1 (en) * | 2003-12-19 | 2004-12-23 | Meidong Yang | Skin and hair cleansers containing sulfur |
| US7648992B2 (en) | 2004-07-05 | 2010-01-19 | Astrazeneca Ab | Hydantoin derivatives for the treatment of obstructive airway diseases |
| SE0401762D0 (sv) * | 2004-07-05 | 2004-07-05 | Astrazeneca Ab | Novel compounds |
| SE0403085D0 (sv) * | 2004-12-17 | 2004-12-17 | Astrazeneca Ab | Novel componds |
| SE0403086D0 (sv) * | 2004-12-17 | 2004-12-17 | Astrazeneca Ab | Compounds |
| TW200831488A (en) * | 2006-11-29 | 2008-08-01 | Astrazeneca Ab | Novel compounds |
| PL227790B1 (pl) | 2015-08-13 | 2018-01-31 | Slaski Univ Medyczny W Katowicach | Fosfoniany acetylenowych pochodnych betuliny o działaniu przeciwnowotworowym, sposób ich wytwarzania i zastosowanie. |
| CN120617250A (zh) * | 2025-07-04 | 2025-09-12 | 南京农业大学 | 小分子化合物Nec-1s在制备治疗脑膜炎药物中的应用 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3348725B2 (ja) * | 1992-04-07 | 2002-11-20 | ブリティッシュ バイオテック ファーマシューティカルズ リミテッド | ヒドロキサム酸ベースのコラゲナーゼとサイトカイン阻害剤 |
| GB9215665D0 (en) * | 1992-07-23 | 1992-09-09 | British Bio Technology | Compounds |
| GB9323165D0 (en) * | 1993-11-10 | 1994-01-05 | Chiros Ltd | Compounds |
| GB9404046D0 (en) * | 1994-03-03 | 1994-04-20 | Smithkline Beecham Corp | Novel compounds |
| ES2133807T3 (es) * | 1994-10-05 | 1999-09-16 | Darwin Discovery Ltd | Compuestos de peptidilo y su uso terapeutico como inhibidores de metaloproteasas. |
-
1996
- 1996-11-22 CA CA002229438A patent/CA2229438C/en not_active Expired - Fee Related
- 1996-11-22 DE DE69620639T patent/DE69620639T2/de not_active Expired - Fee Related
- 1996-11-22 JP JP9519522A patent/JP2000500482A/ja not_active Ceased
- 1996-11-22 CZ CZ19981455A patent/CZ291337B6/cs not_active IP Right Cessation
- 1996-11-22 NZ NZ322565A patent/NZ322565A/xx unknown
- 1996-11-22 BR BR9611636-6A patent/BR9611636A/pt unknown
- 1996-11-22 IL IL12343196A patent/IL123431A/en not_active IP Right Cessation
- 1996-11-22 PL PL96326710A patent/PL326710A1/xx unknown
- 1996-11-22 US US08/755,071 patent/US6048841A/en not_active Expired - Fee Related
- 1996-11-22 EP EP96939208A patent/EP0874842B1/en not_active Expired - Lifetime
- 1996-11-22 HU HU9904131A patent/HUP9904131A3/hu unknown
- 1996-11-22 AT AT96939208T patent/ATE215946T1/de not_active IP Right Cessation
- 1996-11-22 AU AU76343/96A patent/AU711907B2/en not_active Ceased
- 1996-11-22 KR KR1019980703717A patent/KR19990067687A/ko not_active Ceased
- 1996-11-22 WO PCT/GB1996/002892 patent/WO1997019075A1/en not_active Ceased
- 1996-11-22 ES ES96939208T patent/ES2172690T3/es not_active Expired - Lifetime
- 1996-11-22 CN CN96198507A patent/CN1072667C/zh not_active Expired - Fee Related
-
1998
- 1998-05-20 NO NO982290A patent/NO982290D0/no not_active Application Discontinuation
- 1998-05-21 MX MX9804052A patent/MX9804052A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CZ145598A3 (cs) | 1998-08-12 |
| WO1997019075A1 (en) | 1997-05-29 |
| AU7634396A (en) | 1997-06-11 |
| HUP9904131A2 (hu) | 2000-06-28 |
| IL123431A (en) | 2001-05-20 |
| HUP9904131A3 (en) | 2002-04-29 |
| EP0874842B1 (en) | 2002-04-10 |
| AU711907B2 (en) | 1999-10-21 |
| NO982290L (no) | 1998-05-20 |
| ES2172690T3 (es) | 2002-10-01 |
| NZ322565A (en) | 1999-11-29 |
| CN1202895A (zh) | 1998-12-23 |
| IL123431A0 (en) | 1998-09-24 |
| PL326710A1 (en) | 1998-10-26 |
| JP2000500482A (ja) | 2000-01-18 |
| CA2229438A1 (en) | 1997-05-29 |
| US6048841A (en) | 2000-04-11 |
| MX9804052A (es) | 1998-09-30 |
| CA2229438C (en) | 2006-01-17 |
| CN1072667C (zh) | 2001-10-10 |
| DE69620639T2 (de) | 2002-10-17 |
| NO982290D0 (no) | 1998-05-20 |
| DE69620639D1 (de) | 2002-05-16 |
| BR9611636A (pt) | 1999-12-28 |
| EP0874842A1 (en) | 1998-11-04 |
| CZ291337B6 (cs) | 2003-02-12 |
| KR19990067687A (ko) | 1999-08-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69620639D1 (de) | Mercaptoalkylpeptidylverbindungen mit einem imidazolsubstituenten und ihre verwendung als inhibitoren der matrix metalloproteinasen (mmp) und/oder des tumor necrosis faktors (tnf) | |
| ATE188969T1 (de) | Peptidverbindungen und ihre therapeutische verwendung als inhibitoren von metalloproteinasen | |
| PL319503A1 (en) | Peptide compounds and their therapeutic application as inhibitors | |
| ATE266000T1 (de) | Hydroxamsäure- und carbonsäure-derivate mit mmp und tnf hemmender wirkung | |
| DE69628019D1 (de) | Chinolone und deren therapeutische verwendung | |
| DE69835518D1 (de) | Imidazolyl-cyclische acetale | |
| DE69722656D1 (de) | Bicyclische arylcarboxamide und ihre therapeutische verwendung | |
| DE69836563D1 (de) | INHIBIERUNG DER p38 KINASE-AKTIVITÄT DURCH DIE VERWENDUNG VON ARYL- UND HETEROARYLSUBSTITUIERTEN HARNSTOFFEN | |
| FI980038L (fi) | Tuumorinekroositekijän alfa inhibiittoreita | |
| ATE200677T1 (de) | Substituierte tetra- und pentapeptid hemmstoffe der farnesyl protein transferase | |
| BG104996A (en) | Indole derivatives and their use in the treatment of malignant and other diseases caused by pathological cell proliferation | |
| IL122782A (en) | Triazole salts and pharmaceutical compositions containing the same and methods for evaluating the susceptibility of a cancer to growth inhibition utilizing the same | |
| ATE231837T1 (de) | Hydroxamsäure- und carbonsäurederivate mit mmp und tnf hemmender wirkung | |
| ATE292626T1 (de) | Substituierte indazolderivate und ihre verwendung als inhibitoren des phosphodiesterase (pde) des typs iv und der produktion des tumor nekrosis faktors (tnf) | |
| BG103832A (en) | Leptin as tumour cells proliferation inhibitor | |
| ES2000734A6 (es) | Un procedimiento para la preparacion de pirimidinas | |
| DE69814444D1 (de) | Kombination von angiotensing-convertin-enzyme hemmern mit diuretikum zur behandlung von störungen der mikrozirkulation | |
| ATE174219T1 (de) | Verwendung von leflunomid zur hemmung von tumornekrosefaktor alpha | |
| DK1051395T3 (da) | N-hydroxyformamidderivater | |
| ATE229034T1 (de) | 3-mercaptoacetylamino-1,5-substituierte-2-oxo- azepan derivate und deren verwendung als inhibitoren von matrix-metalloproteinasen | |
| ATE352306T1 (de) | Ein präkursor der harnsäure und ein antioxidationsmittel enthaltende zusammensetzung und deren verwendung zur behandlung von neurodegenerativen erkrankungen | |
| ATE358673T1 (de) | Nf-kb-inhibitoren | |
| WO2005046658A3 (en) | Methods of modulating angiogenesis and cancer cell proliferation | |
| HK1012191A (en) | Mercaptoalkylpeptidyl compounds having an imidazole substituent and their use as inhibitors of matrix metalloproteinases (mmp) and/or tumour necrosis factor (tnf) | |
| ATE215935T1 (de) | Heterozyklische verbidungen mit mmp und tnf inhibitorisher wirkung |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |